top of page Experience Our Expertise Explore the art of enhancing natural beauty at Flawless Cosmetic
Arch Med Res 48(6):506512
20, 2025) used clinical data to analyze the primary intended effects of GLP-1RAs and secondary effects across multiple health conditions
Front Endocrinol 10:524 Arias-Loste MT, Ranchal I, Romero-Gmez M, Crespo J (2014) Irisin, a link among fatty liver disease, physical inactivity and insulin resistance
Recent studies highlight how GLP-1 receptor agonistsincluding Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound)exhibit powerful anti-inflammatory effects
10.1038/s41531-018-0044-6 NPJ Parkinsons Dis